CoChat

Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector

Open access
Okumura, Takashi, Horie, Yumi, Lai, Chen-Yi, Lin, Huan-Ting, Shoda, Hirofumi, Natsumoto, Bunki, Fujio, Keishi, Kumaki, Eri, Okano, Tsubasa, Ono, Shintaro, Tanita, Kay, Morio, Tomohiro, Kanegane, Hirokazu, Hasegawa, Hisanori, Mizoguchi, Fumitaka, Kawahata, Kimito, Kohsaka, Hitoshi, Moritake, Hiroshi, Nunoi, Hiroyuki, Waki, Hironori, Tamaru, Shin-ichi, Sasako, Takayoshi, Yamauchi, Toshimasa, Kadowaki, Takashi, Tanaka, Hiroyuki, Kitanaka, Sachiko, Nishimura, Ken, Ohtaka, Manami, Nakanishi, Mahito, Otsu, Makoto · 2019 · Stem Cell Research & Therapy
Cited by 37

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Disease modeling with patient-derived induced pluripotent stem cells (iPSCs) is a powerful tool for elucidating the mechanisms underlying disease pathogenesis and developing safe and effective treatments. Patient peripheral blood (PB) cells are used for iPSC generation in many cases since they can be collected with minimum invasiveness. To derive iPSCs that lack immunoreceptor gene rearrangements, hematopoietic stem and progenitor cells (HSPCs) are often targeted as the reprogramming source. However, the current protocols generally require HSPC mobilization and/or ex vivo expansion owing to their sparsity at the steady state and low reprogramming efficiencies, making the overall procedure costly, laborious, and time-consuming. METHODS: -rich cells to pluripotency, the Sendai virus vector SeVdp-302L was used to transfer four transcription factors: KLF4, OCT4, SOX2, and c-MYC. In this iPSC generation series, the reprogramming efficiencies, success rates of iPSC line establishment, and progression time were recorded. After generating the iPSC frozen stocks, the cell recovery and their residual transgenes, karyotypes, T cell receptor gene rearrangement, pluripotency markers, and differentiation capability were examined. RESULTS: We succeeded in establishing 223 iPSC lines with high reprogramming efficiencies from 15 patients with 8 different disease types. Our method allowed the rapid appearance of primary colonies (~ 8 days), all of which were expandable under feeder-free conditions, enabling robust establishment steps with less workload. After thawing, the established iPSC lines were verified to be pluripotency marker-positive and of non-T cell origin. A majority of the iPSC lines were confirmed to be transgene-free, with normal karyotypes. Their trilineage differentiation capability was also verified in a defined in vitro assay. CONCLUSION: This robust and highly efficient method enables the rapid and cost-effective establishment of transgene-free iPSC lines from a small volume of PB, thus facilitating the biobanking of patient-derived iPSCs and their use for the modeling of various diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-019-1273-2

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 37

Metadata

Authors
Okumura, T., Horie, Y., Lai, C.-Y., Lin, H.-T., Shoda, H., Natsumoto, B., Fujio, K., Kumaki, E., Okano, T., Ono, S., Tanita, K., Morio, T., Kanegane, H., Hasegawa, H., Mizoguchi, F., Kawahata, K., Kohsaka, H., Moritake, H., Nunoi, H., Waki, H., Tamaru, S.-I., Sasako, T., Yamauchi, T., Kadowaki, T., Tanaka, H., Kitanaka, S., Nishimura, K., Ohtaka, M., Nakanishi, M., & Otsu, M.
Venue
Stem Cell Research & Therapy
Published
2019-06-24
Volume
10
Issue
1
Pages
185-185
ISSN
1757-6512 (ISSN-L)
OpenAlex
W2949844821
Cited by
37
References
12
FWCI
1.58
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector. https://app.cochat.ai/papers/10.1186/s13287-019-1273-2
The paper
Okumura, T., Horie, Y., Lai, C.-Y., Lin, H.-T., Shoda, H., Natsumoto, B., Fujio, K., Kumaki, E., Okano, T., Ono, S., Tanita, K., Morio, T., Kanegane, H., Hasegawa, H., Mizoguchi, F., Kawahata, K., Kohsaka, H., Moritake, H., Nunoi, H., . . . Otsu, M. (2019). Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-019-1273-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.